Adding probiotics to antipsychotic treatment is associated with a significant decrease in schizophrenia symptoms, a new ...

The "Sinusitis Pipeline Insight Analysis Report" drug pipelines has been added to ResearchAndMarkets.com's offering.The sinusitis treatment pipeline analysis provides an overview of recent ...

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and ...

Virtual reality technology is linked to greater motor rehabilitation improvements in critically ill patients than traditional ...

To predict arrhythmic risk in carriers of filamin C truncating variants, a novel risk predictive model was developed based on ...

Concomitant use of statins improved survival among people with cancer treated with immune checkpoint inhibitors, according to ...

Among patients with low-grade, intermediate-risk NMIBC, UGN-102 generated robust, durable responses in an analysis of the ...

Jill Collins, CEO, Chief Strategy Officer, Audacity Health.

Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency ...

CluePoints named as Finalist in 2025 ACDM AwardsThe Company, along with its Research and Development Teams, were shortlisted for continuing its mission of turning artificial intelligence into a force ...

We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...